Intrinsic and extrinsic apoptosis responses in leukaemia cells following daunorubicin treatment

BACKGROUND: Daunorubicin is used clinically in the treatment of myeloma, acute lymphatic and myelocytic leukaemia. The toxic lesions caused by daunorubicin induce various modes of cell death, including apoptosis. Apoptosis is highly regulated programmed cell death that can be initiated mainly via tw...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Aamri, Hussain Mubarak, Irving, Helen R., Bradley, Christopher, Meehan-Andrews, Terri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059319/
https://www.ncbi.nlm.nih.gov/pubmed/33879127
http://dx.doi.org/10.1186/s12885-021-08167-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059319/
https://www.ncbi.nlm.nih.gov/pubmed/33879127
http://dx.doi.org/10.1186/s12885-021-08167-y

Ejemplares similares